HP
GILD icon

Havemeyer Place’s Gilead Sciences GILD Stock Holding History

Havemeyer Place’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Sell
1,661
-3,789
-70% -$499K 0.02% 452
2026
Q1 		$760K Sell
5,450
-2,238
-29% -$313K 0.09% 355
2025
Q4 		$944K Buy
+7,688
New +$934K 0.19% 200

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Havemeyer Place's GILD Position: Q2 2026 in Review

Havemeyer Place reduced its Gilead Sciences (GILD) stake by 70% in Q2 2026, selling an estimated $499K and leaving 1,661 shares worth $210K. The position accounts for 0.02% of the portfolio, ranked #452.

Havemeyer Place first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $944K in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Havemeyer Place held 1,661 shares of Gilead Sciences worth $210K as of Q2 2026.
  • Havemeyer Place sold 3,789 Gilead Sciences shares in Q2 2026, an estimated $499K.
  • Gilead Sciences made up 0.02% of Havemeyer Place's portfolio in Q2 2026, its #452 holding.
  • Havemeyer Place first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Havemeyer Place's Gilead Sciences position peaked at $944K in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Havemeyer Place's 13F filing for Q2 2026, filed 13 Aug 2026.